Enhanced airway inflammation and decreased subepithelial fibrosis in interleukin 6-deficient mice following chronic exposure to aerosolized antigen

Clinical and Experimental Allergy

Volumn 34, Issue 8, 2004, Pages 1321-1328

  Qiu, Z ^a,b   Fujimura, M ^a   Kurashima, K ^a   Nakao, S ^a   Mukaida, N ^c  

^a KANAZAWA UNIVERSITY GRADUATE SCHOOL OF MEDICAL SCIENCE   (Japan)

^b TONGJI UNIVERSITY   (China)

^c KANAZAWA UNIVERSITY   (Japan)

Author keywords

Airway hyper responsiveness; Airway inflammation; Airway remodelling; Chemokines; Chronic antigen exposure; Cytokines; IL 6 deficient mice

Indexed keywords

CHEMOKINE; CYTOKINE; EOTAXIN; INTERLEUKIN 13; INTERLEUKIN 4; INTERLEUKIN 6; MESSENGER RNA; METHACHOLINE; MONOCYTE CHEMOTACTIC PROTEIN 1; OVALBUMIN; TRANSFORMING GROWTH FACTOR BETA1;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIGEN EXPRESSION; ARTICLE; BASEMENT MEMBRANE; BRONCHUS HYPERREACTIVITY; CHRONICITY; COLLAGEN SYNTHESIS; CONTROLLED STUDY; EOSINOPHIL; FEMALE; FIBROSIS; LUNG LAVAGE; LYMPHOCYTE; LYMPHOCYTIC INFILTRATION; MOUSE; NEUTROPHIL; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; RESPIRATORY TRACT INFLAMMATION; SENSITIZATION; WILD TYPE;

AEROSOLS; ALLERGENS; ANIMALS; ASTHMA; BRONCHOALVEOLAR LAVAGE FLUID; CELL COUNT; CHEMOKINES; CHRONIC DISEASE; COLLAGEN; CYTOKINES; FEMALE; FIBROSIS; GROWTH SUBSTANCES; INTERLEUKIN-6; LUNG; MICE; MICE, INBRED BALB C; MICE, KNOCKOUT; MODELS, ANIMAL; OVALBUMIN;

EID: 4143119932     PISSN: 09547894     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1365-2222.2004.02013.x     Document Type: Article

References (49)

1. Rossi GA, Crimi E, Lantero S et al. Late-phase asthmatic reaction to inhaled allergen is associated with early recruitment of eosinophils in the airway. Am Rev Respir Dis 1991; 144:379-83.
2. Bousquet J, Chanez P, Lacoste J-Y et al. Eosinophilic inflammation in asthma. J Clin Invest 1990; 323:1033-9.
3. Ollerenshaw SL, Woolcock AJ. Characteristics of the inflammation in biopsies from large airways of subjects with asthma and subjects with chronic airflow limitation. Am Rev Respir Dis 1992; 145:922-7.
4. Crimi E, Spanevello A, Neri M, Ind PW, Rossi GA, Brusasco V. Dissociation between airway inflammation and airway hyperresponsiveness in allergic asthma. Am J Respir Crit Care Med 1998; 157:4-9.
5. Wiggs BR, Bosken C, Pare PD, James A, Hogg JC. A model of airway narrowing in asthma and in chronic obstructive pulmonary disease. Am Rev Respir Dis 1992; 145:1251-8.
6. Brewster CEP, Howarth PH, Djukanovic R, Wilson J, Holgate ST, Roche WR. Myofibroblast and subepithelial fibrosis in bronchial asthma. Am J Respir Cell Mol Biol 1990; 3:507-11.
7. Roche WR, Beasley R, Williams JH, Holgate ST. Sub-epithelial fibrosis in the bronchi of asthmatics. Lancet 1989; 1:520-4.
8. Wilson JW, Li X. The measurement of reticular basement membrane and submucosal collagen in the asthmatic airway. Clin Exp Allergy 1997; 27:363-71.
9. Laitinen A, Altraja A, Kampe M, Linden M, Virtanen I, Laitinen LA. Tenascin is increased in airway basement membrane of asthmatics and decreased by an inhaled steroid. Am J Respir Crit Care Med 1997; 156:951-8.
10. Lange P, Parner J, Vestbo J, Schnohr P, Jensen GA. A 15-year follow-up study of ventilatory function in adults with asthma. N Engl J Med 1998; 339:1194-200.
11. Chetta A, Foresi A, Del Donno M, Bertorelli G, Pesci A, Olivieri D. Airway remodeling is a distinctive feature of asthma and is related to severity of disease. Chest 1997; 111:852-7.
12. Selroos O, Pietinalho A, Lofroos A, Riska H. Effect of early vs late intervention with inhaled corticosteroids in asthma. Chest 1998; 108:1228-34.
13. Kips JC, Pauwels RA. Airway remodeling: does it occur and what does it mean? Clin Exp Allergy 1999; 29:1457-66.
14. Kishimoto T, Akira S, Narazaki M, Taga T. Interleukin-6 family of cytokines and gp 130. Blood 1995; 86:1243-54.
15. Papanicolaou DA, Wilder RL, Manolagas SC, Chrousos GP. The pathophysiologic role of interleukin-6 in human disease. Ann Intern Med 1998; 128:127-37.
16. Yokoyama A, Kohno N, Fujino S et al. Circulation interleukin-6 in patients with bronchial asthma. Am J Crit Care Med 1995; 151:1354-8.
17. Broide DH, Lotz M, Cuomo AJ, Coburn DA, Federman EC, Wasserman SI. Cytokines in symptomatic asthma airways. J Allergy Clin Immunol 1992; 89:958-67.
18. Marini M, Vittori E, Hollemborg J, Mattoli S. Expression of the potent inflammatory cytokines, granulocyte-macrophage-colony-stimulating factor and interleukin-6 and interleukin-8, in bronchial epithelial cells of patients with asthma. J Allergy Clin Immunol 1992;89:1001-9.
19. DiCosmo BF, Geba GP, Picarella D et al. Airway epithelial cell expression of interleukin-6 in transgenic mice. Uncoupling of airway inflammation and bronchial hyperreactivity. J Clin Invest 1994; 94:2028-35.
20. Kuhn C, Home RJ, Zhu Z et al. Airway hyperresponsiveness and airway obstruction in transgenic mice. Morphologic correlates in mice overexpressing interleukin (IL)-11 and IL-6 in the lung. Am J Respir Cell Mol Biol 2000; 22:289-95.
21. Vercelli D, Jabara H, Arai K, Yokota T, Geha RS. Endogenous IL-6 plays an obligatory role in IL-4 dependent IgE synthesis. Eur J Immunol 1989; 19:1419-24.
22. Rincon M, Anguita J, Nakamura T, Fikrig E, Flavell RA. Interleukin (IL)-6 directs the differentiation of IL-4 producing CD4+ T cells. J Exp Med 1997; 185:461-9.
23. Denis M. Interleukin-6 in mouse hypersensitivity pneumonitis; changes in lung free cells following depletion of endogenous IL-6 or direct administration of IL-6. J Leukoc Biol 1992; 52:197-201.
24. Xing Z, Gauldie J, Cox G et al. IL-6 is an antiinflammatory cytokine required for controlling local or systemic acute inflammatory responses. J Clin Invest 1998; 101:311-20.
25. Wang J, Homer RJ, Chen Q, Elias JA. Endogenous and exogenous IL-6 inhibit aeroallergen-induced Th2 inflammation. J Immunol 2000; 165:4051-61.
26. Panettieri Jr RA, Murray PK, Eszterhas AJ, Bilgen G, Martin JG. Repeated allergen inhalations induce DNA synthesis in airway smooth muscle and epithelial cells in vivo. Am J Physiol 1998; 274:L417-24.
27. Trifilieff A, EI-Hashim A, Bertrand C. Time course of inflammatory and remodeling events in a murine model of asthma: effect of steroid treatment. Am J Physiol 2000; 279:L1120-8.
28. Kopf M, Baumann H, Freer G et al. Impaired immune and acute phase response in interleukin-6-deficient mice. Nature 1994; 368:339-42.
29. Natsume M, Tsuji H, Harada A et al. Attenuated liver fibrosis and depressed serum albumin levels in carbon tetrachloride-treated IL-6-deficient mice. J Leukoc Biol 1999; 66:601-8.
30. Temelkovski J, Hogan SP, Shepherd DP, Foster PS, Kumar PK. An improved murine model of asthma: selective airway inflammation, epithelial lesions and increased methacholine responsiveness following chronic exposure to aerosolised allergen. Thorax 1998; 53:849-56.
31. Sogur N, Fujimura M, Mizuhashi K, Saito M, Xiu QY, Matsuda T. Involvement of thromboxane A2 in propranolol-induced bronchoconstriction after allergic bronchoconstriction in guinea pigs. Am J Respir Crit Care Med 1994; 149:1488-93.
32. Sullivan P, Stephens D, Ansari T, Costello J, Jeffery P. Variation in the measurements of basement membrane thickness and inflammatory cell number in bronchial biopsies. Eur Respir J 1998; 12:811-5.
33. Foster PS, Hogan SP, Ramsay AJ, Matthaei KI, Young IG. Interleukin 5 deficiency abolishes eosinophilia, airway hyperreactivity, and lung damage in a mouse asthma model. J Exp Med 1996; 183:195-201.
34. Sahabuddin S, Ponath P, Schleimer RP. Migration of eosinophils across endoepithelial cell monolayers: interactions among IL-5, endothelial-activating cytokines, and C-C chemokines. J Immunol 2000; 164:3847-54.
35. Gavett SH, O'Hearn DJ, Karp CL et al. Interleukin-4 receptor blockade prevents airway responsiveness induced by antigen challenge in mice. Am J Pathol 1997; 272:L253-61.
36. Wills-Karp M, Luyimbazi J, Xu X et al. Interleukin-13: central mediator of allergic asthma. Science 1998; 282:2258-60.
37. Sur S, Crotty TB, Kephart GM et al. Sudden-onset fatal asthma. A distinct entity with few eosinophils and relatively more neutrophils in the airway submucosa? Am Rev Respir Dis 1993; 148:713-9.
38. Fahy JV, Kim KW, Liu J, Boushey HA. Prominent neutrophilic inflammation in sputum from subjects with asthma exacerbation. J Allergy Clin Immunol 1995; 95:843-52.
39. Sampson AP. The role of eosinophils and neutrophils in inflammation. Clin Exp Allergy 2000; 30 (Suppl. 1):22-7.
40. Johnston B, Burns AR, Suematsu M, Issekutz TB, Woodman RC, Kubes P. Chronic inflammation upregulates chemokine receptors and induces neutrophils migration to monocyte chemoattractant protein-1. J Clin Invest 1999; 103:1269-76.
41. Moreno RH, Hogg JC, Pare PD. Mechanics in airway narrowing. Am Rev Respir Dis 1986; 133:1171-80.
42. Wiggs BR, Hrousis CA, Drazen JM, Kamm RD. On the mechanism of mucosal folding in normal and asthmatic airways. J Appl Physiol 1997; 83:1814-21.
43. Lambert RK, Codd SL, Alley MR, Pack RJ. Physical determinants of bronchial mucosal folding. J Appl Physiol 1994; 77:1206-16.
44. Palman E, Kips JC, Pauwels RA. Prolonged allergen exposure induces structural airway changes in sensitized rats. Am J Respir Crit Care Med 2000; 161:627-35.
45. Kuhn C, McDonald JA. The roles of myofibroblast in idiopathic pulmonary fibrosis: ultrastructural and immunohistochemical features of sites of active extracellular matrix synthesis. Am J Pathol 1991; 138:1257-65.
46. Shahar I, Fireman E, Topilsky M et al. Effect of IL-6 on alveolar fibroblast proliferation in interstitial lung diseases. Clin Immunol Immunopathol 1996; 79:244-51.
47. Jikko A, Wakisaki T, Iwamoto M et al. Effects of interleukin-6 on proliferation and proteoglycan metabolism in articular chondrocyte cultures. Cell Biol Int 1998; 22:615-21.
48. Choi I, Kang HS, Yang Y, Pyun KH. IL-6 induces hepatic inflammation and collagen synthesis in vivo. Clin Exp Immunol 1994; 95:530-5.
49. Gallucci RM, Simeonova PP, Matheson JM et al. Impaired cutaneous wound healing in interleukin-6-deficient and immunosuppressed mice. FASEB J 2000; 14:2525-31.